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Escherichia coliOptimising membrane protein production yields in Escherichia coli can be time- and resource-
consuming. Here, we present a simple and effective Membrane protein Single shot ampliﬁcation
recipe: MemStar. This one-shot ampliﬁcation recipe is based on the E. coli strain Lemo21(DE3),
the PASM-5052 auto-induction medium and, contradictorily, an IPTG induction step. Using
MemStar, production yields for most bacterial membrane proteins tested were improved to reach
an average of 5 mg L1 per OD600 unit, which is signiﬁcantly higher than yields obtained with other
common production strategies. With MemStar, we have been able to obtain new structural informa-
tion for several transporters, including the sodium/proton antiporter NapA.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Crystal structures of bacterial membrane proteins introduce a
wealth of mechanistic insight and can also be useful model sys-
tems for understanding the function of membrane proteins from
higher eukaryotes e.g., [1]. However, obtaining well-diffracting
bacterial membrane protein crystals for X-ray crystallography is
usually based on labour-intensive screening approaches. It is rou-
tine to screen a large selection of homologues to identify those that
are intrinsically the most stable in detergent solution as this has
been shown to be a faster route for obtaining crystal structures
[2]. Unfortunately, because there is no clear correlation between
membrane protein production levels and detergent-solubilised
protein stability [3,4], the most tractable targets might be those
that can only be produced to low levels. Although low yields are
not an insurmountable problem, they can hinder structural efforts
due to excessive detergent over-concentration during puriﬁcation
in large-sized detergents and/or the additional costs associatedwith low puriﬁcation yields in small micelle-sized detergents
[2,5]. Clearly, it is important to increase the fraction of highly
producing membrane proteins, as this will directly facilitate struc-
tural studies by making it feasible to work with a larger selection of
homologues. Furthermore, with higher puriﬁcation yields the
number of crystallisation screens can be increased whilst decreas-
ing detergent costs. For structural investigations of bacterial
membrane proteins Escherichia coli is by far the most widely used
production host [6]. Often different strains, culture conditions and
target gene expression regimes are screened in an attempt to iden-
tify a production strategy that yields workable amounts of protein
for structural studies.
Here, we outline the development of aMembrane protein Single
shot ampliﬁcation recipe (MemStar), which is based on the E. coli
strain Lemo21(DE3), the PASM-5052 protein production medium
and an isopropyl b-D-1-thiogalactopyranoside (IPTG) induction
step. With MemStar, we could increase the amount of target
produced per OD600 unit to signiﬁcantly higher levels than the
standard conditions generally tested.2. Materials and methods
All reagents and chemicals were from Sigma–Aldrich.
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Control proteins were cloned into the pET28(a) derivative
pWaldo-GFPe as GFP-His8 fusions [7].
Media used for production were prepared as follows:
 Luria Broth (LB): 10 g Bacto-tryptone, 5 g Bacto-Yeast
Extract and 5 g NaCl (sodium chloride) added to 1000 mL
of distilled water for autoclaving.
 Terriﬁc Broth (TB): 12 g casein yeast peptone, 24 g yeast
extract and 4 mL of 100% glycerol added to 800 mL distilled
water for autoclaving, followed by the addition of 100 mL
of ﬁlter-sterilised solution of 0.17 M KH2PO4 and 0.72 M
K2HPO4.
Auto-induction media used for production were prepared as
according to Studier [8] as follows:
 ZYM-5052: 1% (w/v) N-Z-amine AS, 0.5% (w/v) yeast extract,
25 mMNa2HPO4, 25 mMKH2PO4, 50 mMNH4Cl, 5 mMNa2-
SO4, 2 mM MgSO4, 0.2 metals, 0.5% (v/v) glycerol, 0.05%
(w/v) glucose and 0.2% (w/v) a-lactose.
 PASM-5052: 50 mM Na2HPO4, 50 mM KH2PO4, 25 mM
(NH4)2SO4, 2 mM MgSO4, 0.2 metals, 0.5% (v/v) glycerol,
0.05% (w/v) glucose, 0.2% (w/v) a-lactose, 200 lg/mL each
of 17 amino acids (tyrosine and cysteine not included),
500 lg/mL methionine, 125 lg/mL selenomethionine
(Generon) (optional) and 100 nM vitamin B12.
 Transformations and media were supplemented with
kanamycin (50 lg/mL) using either the E. coli strain
C43(DE3) [9] or Lemo21(DE3) [10]. Media used to culture
Lemo21(DE3) were also supplemented with chloramphen-
icol (30 lg/mL).
2.2. Membrane protein production screening
Overnight C43(DE3) cultures from fresh transformations were
grown in LB and diluted 1:50-fold into either LB, TB, ZYM-5052 or
PASM-5052 and incubated at 37 C to an OD600 of 0.5 followed by
overnight incubation at 25 C with or without the addition of
0.4 mM IPTG. Overnight Lemo21(DE3) cultures were likewise
grown in LB and diluted 1:50-fold into either LB or PASM-5052 sup-
plemented with increasing concentrations of L-rhamnose as indi-
cated and incubated at 37 C to an OD600 of 0.5 followed by
overnight incubation at 25 C with the addition of 0.4 mM IPTG.
Small-sized production screening was carried out in 24-deep well
blocks (Invitrogen, Cat. No. CS15124) containing 4 mL media and
large-scale expression of 1 L media cultures of LB and PASM-5052
in 2.5 L bafﬂed Tunair shaker ﬂasks (Sigma, Z710822). Production
levels were calculated based on GFP ﬂuorescence (excitation
488 nm, emission 512 nm) from 1 mL sized culture samples resus-
pended in 100 uL of 1 PBS buffer and transferred to a 96-well
black clear bottom plate (Nunc), as previously described [7,11].2.3. Membrane isolation, FSEC screening and protein puriﬁcation
1 L cultures of C43(DE3) cells producing membrane protein
GFP-fusions in LB, or Lemo21(DE3) cells producing membrane pro-
tein GFP-fusions in PASM-5052 with IPTG induction and the opti-
mum L-rhamnose concentration were used as starting material
for the isolation of membranes. Isolated cells were broken with 2
passes at 25 kpsi with mechanical disruption using the Constant
Systems cell disrupter. Unbroken cells were cleared by centrifuga-
tion at 16000g for 12 min at 4 C. Membranes were isolated by
centrifugation of supernatant at 120000g for 2 h and resus-
pended in 1 PBS buffer.2.3.1. Membrane-solubilised FSEC
Membranes isolated from the C43(DE3) conditions were diluted
to 3.5 mg L1 in buffer containing 1 PBS, 150 mMNaCl and 1% (w/
v) DDM (Generon). Membranes isolated from the MemStar condi-
tions were diluted by the equivalent dilution factor (1.5–2.0-fold)
applied to total membranes isolated from the C43(DE3) conditions.
Detergent-solubilised membranes were incubated for 1 h at 4 C
with continuous stirring and non-solubilised material removed by
ultracentrifugation at 120000g for 45 min. A 0.1 mL aliquot of
detergent-solubilised supernatant was diluted 5-fold, to not satu-
rate the ﬂuorescent detector, and loaded onto a Superose 6 column
(10/30, GE-healthcare) pre-equilibrated with 20 mM Tris–HCl pH
7.5, 150 mM NaCl, 0.03% (w/v) DDM at a ﬂow rate of 0.4 mL/min.
GFP ﬂuorescence was monitored (emission wavelength of 512 nm
and excitation wavelength of 488 nm) using an inline-detector
Shimadzu HPLC system (Shimadzu Corporation).
2.3.2. Whole-cell FSEC and membrane protein puriﬁcation
1 mL of culture was centrifuged at 14000g for 10 min at room
temperature. The supernatant was then discarded and the cell pel-
lets resuspended in buffer containing 1 PBS, 150 mM NaCl and 1%
(w/v) DDM (Generon) to a ﬁnal volume of 1 mL and allowed to incu-
bate for 1 h at 4 C with gentle stirring. The samples were then cen-
trifuged at 14000g for 10 min at 4 C to remove non-solubilised
materials. A 0.1 mL aliquot of detergent-solubilised supernatant
was diluted appropriately, to not saturate the ﬂuorescent detector,
and loaded onto a BioSep™ 5 lm SEC-s3000 400 Å, LC Column
(Phenomenex, Part No. 00H-2146-K0) pre-equilibrated with
20 mM Tris–HCl pH 7.5, 150 mM NaCl, 0.03% (w/v) DDM at a ﬂow
rate of 1 mL/min respectively at room temperature. GFP ﬂuores-
cence was monitored as described above and the resulting FSEC
traces normalized.
For puriﬁcation, membranes isolated from 5 L MemStar cultures
were solubilised in 1% (w/v) DDM for 2 h in 360 mLs of buffer con-
taining 1  PBS, 150 mM NaCl and 10 mM imidazole pH 7.5. The
suspension was cleared by ultracentrifugation at 120000g for
1 h. Target proteins were puriﬁed by Ni–NTA afﬁnity chromatogra-
phy, followed by dialysis, GFP-His8-tag cleavage and tag removal as
previously described in detail [7,36]. After gel ﬁltration the protein
peak was collected and concentrated to 10 mg/mL using Vivaspin
50 K centrifugal concentrators (Sartorius Stedim Biotech) for crys-
tallisation screening.
2.4. Flow cytometry
Membrane protein production was monitored on a cell popula-
tion level, from small-scale cultures using a FACSCalibur instru-
ment (BD Biosciences) as previously described [10]. Brieﬂy, cells
diluted in PBS were gated based on the membrane staining dye
FM4-64 (Invitrogen) with GFP ﬂuorescence detected logarithmi-
cally. The FlowJo software (Treestar) was used for raw data analy-
sis and data processing.3. Results and discussion
3.1. Optimising membrane protein production per OD600 unit in the
E. coli strain C43(DE3)
In our search for alternatives that perform better than the cur-
rently used E. coli-basedmembrane protein production approaches,
we re-evaluated the production of ten model membrane protein
targets (see below) in thewidely used E. colimembrane protein pro-
duction strain C43(DE3) [9]. This strain was evolved from the E. coli
strain BL21(DE3) to have improved membrane protein production
characteristics. In BL21(DE3) expression of the target gene is driven
Table 1
List of control membrane protein targets used for developing MemStar.
Membrane
Protein
Function Species Refs.
Mhp1 Benzyl-hydantoin
transporter
Microbacterium
liquefaciens
[18]
NhaAa Sodium/proton antiporter Escherichia coli [16]
Yiip Zinc transporter Escherichia coli [20]
EmrD Multidrug transporter Escherichia coli [21]
GlpG Intramembrane protease Escherichia coli [17]
AsbTNM Sodium/bile acid
transporter
Neisseria meningitidis [14]
GlpT Glycerol-3-phosphate
transporter
Escherichia coli [15]
AmtB Ammonium channel Escherichia coli [19]
LacY Lactose permease Escherichia coli [13]
TehA Tellurite channel Haemophilus inﬂuenza [22]
a A thermostable NhaA mutant (A109T, Q277G and L296M) generated as part of a
separate structure study was used (Lee et al., manuscript under review, PDB code
4ATV).
Table 2
Production summary of control membrane protein targets in the variety of different strains
5052 and C43(DE3)/ZYM-5052 with IPTG induction. (c) C43(DE3)/PASM-5052 and C43(DE3
with IPTG induction.
E. coli strain Media composition Protein MW RFU
(a)
Mhp1 54.6 3
NhaA 41.4 16
Yiip 32.9 28
EmrD 42.2 7
GlpG 31.3 42
C43(DE3) LB AsbTNM 32.9 28
GlpT 50.3 22
AmtB 44.5 16
LacY 46.5 20
TehA 35.9 22
Mhp1 54.6 9
NhaA 41.4 113
Yiip 32.9 171
EmrD 42.2 80
GlpG 31.3 120
C43(DE3) TB AsbTNM 32.9 72
GlpT 50.3 82
AmtB 44.5 49
LacY 46.5 73
TehA 35.9 52
(b)
Mhp1 54.6 14
NhaA 41.4 46
Yiip 32.9 75
EmrD 42.2 106
GlpG 31.3 50
C43(DE3) ZYM-5052 AsbTNM 32.9 95
GlpT 50.3 44
AmtB 44.5 25
LacY 46.5 112
TehA 35.9 40
Mhp1 54.6 12
NhaA 41.4 59
Yiip 32.9 157
EmrD 42.2 71
GlpG 31.3 116
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the control of the IPTG inducible lacUV5 promoter [12]. Key to the
improved membrane protein production characteristics of
C43(DE3) is the partial conversion of the lacUV5 promoter to the
much weaker lac wild-type promoter [10].
As model targets for our re-evaluation exercise, we used bacte-
rial membrane proteins with known crystal structures, Table 1:
Mhp1, NhaA, YiiP, EmrD, GlpG, AsbTNM, GlpT, AmtB, LacY and TehA
[13–22]. To rapidly and accurately monitor production levels of the
ten model targets they were C-terminally fused to the cleavable
His8-tagged folding indicator GFP [7,11].
The ten model targets were produced in C43(DE3) cultured in
Lysogeny Broth (LB, a.k.a. Luria Bertani broth), Terriﬁc Broth (TB)
and the ZYM-5052 and PASM-5052 auto-induction based protein
production culture media [8,23]. Although total membrane protein
production levels are higher in C43(DE3) when using either TB or
the ZYM-5052 and PASM-5052 auto-induction media than in LB
(Table 2a–c), when normalised to cell density (OD600), theand media combinations tested. (a) C43(DE3)/LB and C43(DE3)/TB. (b) C43(DE3)/ZYM-
)/PASM-5052 with IPTG induction. (d) Lemo21(DE3)/LB and Lemo21(DE3)/PASM-5052
Final OD600 Protein production
(mg L1)
Normalised protein
production
(mg L1 OD600)
126 5 2.3 0.5
180 4.4 9 2
395 3.6 12.5 3.5
720 3 4.4 1.5
451 4.7 17.8 3.8
493 3.8 12.6 3.3
891 3.4 15.4 4.5
182 2.6 9.6 3.7
651 2.7 12.9 4.8
755 4 11 2.7
Mean 10.7 3
Median 11.7 3.4
279 9.6 6.8 0.7
043 14.8 62.6 4.2
643 12.4 75.7 6.1
280 11.2 45.4 4.1
518 12 50.5 4.2
000 11.2 31.8 2.8
098 10 55.3 5.5
035 12.2 29.2 2.4
388 12.4 45.7 3.7
980 10.4 25.5 2.5
Mean 42.8 3.6
Median 45.5 3.9
584 17.6 10.7 0.6
253 16.4 25.6 1.6
746 10.8 33.4 3.1
151 10.4 60 5.8
261 11.6 21.1 1.8
680 13 42.2 3.2
406 9.7 29.9 3.1
419 11.2 15.2 1.4
919 11.8 70.3 6
307 12 19.4 1.6
Mean 32.8 2.8
Median 27.8 2.5
818 12.2 9.4 0.8
983 12.8 33.2 2.6
135 11.9 69.3 5.8
858 12.6 40.6 3.2
001 12.1 48.6 4
(continued on next page)
Table 2 (continued)
E. coli strain Media composition Protein MW RFU Final OD600 Protein production
(mg L1)
Normalised protein
production
(mg L1 OD600)
C43(DE3) ZYM-5052 AsbTNM 32.9 124290 12 54.8 4.6
IPTG induction GlpT 50.3 84610 10.6 57 5.4
AmtB 44.5 50308 9 30 3.3
LacY 46.5 100439 15 62.6 4.2
TehA 35.9 110160 15 53 3.5
Mean 45.9 3.7
Median 50.8 3.8
(c)
Mhp1 54.6 9624 10 7 0.7
NhaA 41.4 84924 10 47 4.7
Yiip 32.9 65090 9.4 28.7 3.1
EmrD 42.2 87530 10 49.5 4.9
GlpG 31.3 81201 10 34 3.4
C43(DE3) PASM-5052 AsbTNM 32.9 98625 9.6 43.5 4.5
GlpT 50.3 57471 9.5 38.7 4.1
AmtB 44.5 49255 8.8 29.4 3.3
LacY 46.5 84592 9.4 52.7 5.6
TehA 35.9 58380 13 28.1 2.2
Mean 35.9 3.7
Median 36.4 3.7
Mhp1 54.6 17249 11.4 12.6 1.1
NhaA 41.4 87412 13 48.4 3.7
Yiip 32.9 186555 11 82.3 7.5
EmrD 42.2 89101 9.5 50.4 5.3
GlpG 31.3 175912 13.4 73.8 5.5
C43(DE3) PASM-5052 AsbTNM 32.9 139790 10 61.7 6.2
IPTG induction GlpT 50.3 81723 10.2 55.1 5.4
AmtB 44.5 69738 7.2 41.6 5.8
LacY 46.5 84853 8.4 52.8 6.3
TehA 35.9 106990 12 51.5 4.3
Mean 53 5.1
Median 52.2 5.5
(d)
Mhp1 54.6 10902 4 8 2
NhaA 41.4 16388 4.1 9.1 2.2
Yiip 32.9 31837 3.8 14 3.7
EmrD 42.2 12371 3.7 7 1.9
GlpG 31.3 39202 4.4 16.4 3.7
Lemo21(DE3) LB AsbTNM 32.9 52994 3.7 23.4 6.3
GlpT 50.3 15496 3.4 10.4 3.1
AmtB 44.5 11527 3.1 6.9 2.2
LacY 46.5 5895 4.4 3.7 0.8
TehA 35.9 21492 4.3 10.3 2.4
Mean 10.9 2.8
Median 9.7 2.3
Mhp1 54.6 88720 13.2 64.9 4.9
NhaA 41.4 188137 10 104.2 10.4
Yiip 32.9 267502 11.4 118 10.3
EmrD 42.2 93699 10.4 53 5.1
GlpG 31.3 330579 12.5 138.6 11.1
Lemo21(DE3) PASM-5052 AsbTNM 32.9 221150 10 97.6 9.8
IPTG induction GlpT 50.3 94549 12 63.7 5.3
AmtB 44.5 79244 11.8 47.2 4
LacY 46.5 73010 11.9 45.5 3.8
TehA 35.9 115073 12 55.4 4.6
Mean 78.8 6.9
Median 64.3 5.2
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Table 2a–c. This indicates that the higher membrane protein pro-
duction yields compared to LB when using these richer media is
primarily because of increased biomass. This is a real problem for
membrane protein puriﬁcation as detergent solubilisation efﬁcien-
cies decrease as the amount of total membranes to be solubilised
increase. Our data is consistent with the fact that LB still remains
the most popular choice for structural biologists with 17 out of
the last 20 (bacterial) membrane protein structures published
using material produced in LB (http://blanco.biomol.uci.edu/mpstruc/). To obtain signiﬁcantly higher yields it is necessary to
also increase the amount of membrane protein produced per cell.
We had previously observed that membrane protein production
levels in LB are generally the highest when protein production is
induced during mid-log phase rather than stationary-phase [24].
When using auto-induction media, protein production is induced
during stationary phase [25]. For this reason, we also tested the
auto-induction medium upon IPTG-induction during mid-log
phase, Fig. 1a, Table 2b and c. During the course of our studies it
was reported that the glycerol present in the aforementioned
0a b
c
Fig. 1. Setting the stage for the development of a Membrane protein Single shot ampliﬁcation recipe: MemStar. (a) Box-and-whisker plots illustrating the distribution of
membrane protein production (mg L1) normalised to cell density (OD600) for the 10 model membrane protein targets in each of the different culture conditions as labelled.
The bottom and top of each box represents the 25th and 75th percentile with the whisker lines indicating maximum and minimum production levels. The solid vertical line
represents the median and dashed vertical line the mean in each condition. The coloured boxes represent the culture conditions further tested. With the Lemo21(DE3) strain,
protein production levels are presented using the optimum L-rhamnose concentration, as shown in Supplementary Fig. 3. Unless otherwise stated, the optimum rhamnose
concentration is applied throughout all further experiments using the Lemo21(DE3) strain. (b) Flow cytometry analysis of AsbTNM production in: C43(DE3) cells grown in LB
(red), PASM-5052 (yellow), PASM-5052 with IPTG induction (brown) and Lemo21(DE3) cells grown in PASM-5052 with IPTG induction (blue). The coloured culture
conditions correspond with the box-and-whisker plots in (a) note: AsbTNM was selected due to its close membrane protein production levels (mg L1 OD6001 ) to the normalised
mean production levels of the 10 model targets. (c) Quality of produced control proteins as judged by the raw FSEC proﬁles of DDM-solubilised membranes isolated from
either C43(DE3)/LB (red) [24] or Lemo21(DE3)/PASM-5052 with IPTG induction (blue) conditions (which is later referred to as MemStar).
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gene expression at high aeration [26]. This provided another rea-
son to test the effect of the addition of IPTG on membrane protein
production levels with auto-induction media. Interestingly, IPTG
induction led, for both auto-induction media, to production levels
higher than for either LB or TB, with the PASM-5052 auto-induc-
tion medium giving the highest median production levels when
normalised to cell density; an increase from 3.4 to 5.5 mg L1 OD60-
1, Fig. 1a and Table 2a–c. By using the medium PASM-5052 we can
maintain the same high biomass as achieved in rich media and, by
including an IPTG induction step, also increase the amount each
cell produces.
We have previously shown that a C-terminal GFP fusion reports
on membrane-integrated production levels [11]. Nevertheless,
post-translational degradation of the target can leave the GFP
fusion tag intact, resulting in an overestimate of production levels
from whole-cell measurements. To better estimate target produc-
tion, C43(DE3) cells grown in either LB, TB or PASM-5052/IPTG
were isolated and solubilised directly in the detergent DDM (see
Section 2). The detergent solubilised material was injected directly
onto a size-exclusion column and the amount of fusion assessed byﬂuorescent-detection size exclusion chromatography (FSEC) [27].
As shown in Supplementary Table 1 and Supplementary Fig. 1,
the fraction of fusion in either LB or PASM-5052/IPTG accounted
for 70% to 95% of the total whole-cell ﬂuorescence with the
exception of the target YiiP. In contrast, the fraction of fusion from
all targets in TB was always less compared to cells cultured in
either LB or PASM-5052 with IPTG induction, with the fusion peak
for half of the targets in TB accounting for less than 50% of total
whole-cell ﬂuorescence.
3.2. A further improvement in membrane protein production yields by
using Lemo21(DE3)
We have previously shown that the E. coli strain Lemo21(DE3)
facilitates optimising membrane protein production levels by
reducing the amount of inclusion body formation [28].
Lemo21(DE3) is a BL21(DE3) strain that contains the plasmid
pLemo [10,28]. The pLemo plasmid harbours the gene encoding
T7 lysozyme, a natural inhibitor of T7 RNAP, which is under the
control of the tuneable L-rhamnose promoter, Supplementary
Fig. 2. By including different amounts of L-rhamnose in the culture
3766 C. Lee et al. / FEBS Letters 588 (2014) 3761–3769medium, one can rapidly tune target gene expression intensity to
maximise membrane-integrated production levels.
We decided to test if we could further improve target produc-
tion levels by combining the Lemo21(DE3) strain with the
PASM-5052/IPTG culture condition. Initially, we tested target pro-
duction levels for Lemo21(DE3) and C43(DE3) cells cultured in LB
and, surprisingly, found no real differences in production levels
(Table 2a and d). However, when the targets were produced in
the PASM-5052 medium with an IPTG induction step the mean
production levels increased by 35% in Lemo21(DE3) cells, from
5.1 to 6.9 mg L1 OD6001 (Fig. 1a, Table 2a and d). To analyse the
effect of the different culture conditions more carefully, we carried
out ﬂow cytometry analysis of C43(DE3) and Lemo21(DE3) cells
producing one of the control membrane protein targets, ASBTNM,
using different culture conditions. ASBTNM is produced closest to
the normalised mean production level per OD600 unit in all of the
different strain and culture media combinations. As shown in
Fig. 1b an incremental production increase from C43(DE3) cells
cultured in LB (red line) through to Lemo21(DE3) cells cultured
in PASM-5052 with IPTG induction (blue line), is obtained through
an increase in both the number of cells producing the protein as
well as the amount produced per cell. The most likely explanation
for this is that the auto-induction PASM-5052 medium suppresses
the leakiness of the lacUV5 promoter, which may have been
decreasing the pool of target producing cells, i.e., since the majority
of membrane proteins are toxic to cell-growth [29]. It seems that
with the increased population of expressing cells in the PASM-
5052/IPTG culture condition, we now can take better advantage
of the Lemo21(DE3) strain’s ability at maximising membrane-
integrated production levels.
To better estimate target production levels, membranes were
isolated from 1L cell cultures of C43(DE3)/LB and Lemo21(DE3)/
PASM-5052/IPTG. Because the biomass of Lemo21(DE3)/PASM-
5052/IPTG cultures are, on average, 3-fold higher than those
cultured in C43(DE3)/LB (Table 2a and d), the amount of total
membranes isolated are also 3-fold larger. As the objective of
our study was to achieve more protein from equivalent detergent
usage, however, membranes from both culture conditions were
solubilised with the same amount of detergent, 1% (w/v) DDM
(see Section 2). The mean detergent-extraction efﬁciencies for
membranes isolated from C43(DE3)/LB and Lemo21(DE3)/PASM-
5052/IPTG cultures were 92% and 42%, respectively (Table 3).
Because half of the material is not extracted at this suboptimal
membrane/detergent ratio for the Lemo21(DE3)/PASM-5052/IPTG
condition only 1.5-fold more protein, on average, is obtained from
the larger biomass; the exact loss is somewhat target dependent
(Table 3), but overall it is consistent with our rationale forTable 3
DDM-solubilisation efﬁciencies and FSEC peak height differences of the 10 model
targets from membranes isolated from production in either C43(DE3)/LB or
Lemo21(DE3)/PASM-5052 with IPTG induction.
Protein DDM solubilisation
efﬁciency (%)
Relative ﬂuorescence unit peak height
C43(DE3)/
LB
Lemo21/
PASM-5052
+IPTG
C43(DE3)/
LB
Lemo21/
PASM-5052
+IPTG
Difference
ratio
Mhp1 92 55 850718 20853960 25
NhaA 95 55 1609571 28889430 18
Yiip 88 34 4447087 20413160 5
EmrD 95 58 2274143 21241510 9
GlpG 93 40 3162463 32624050 10
AsbTNM 95 53 3556532 22603930 6
GlpT 87 46 2497352 14760340 6
AmtB 91 31 1840210 12758790 7
LacY 93 41 3539108 16229970 5
TehA 93 47 1287276 10812530 8primarily selecting strain and media combinations based on
increased production per cell. The amount and quality of deter-
gent-solubilised targets were next assessed by FSEC [27]. As shown
in Fig. 1c and Table 3, on average 10-fold more of the target
protein is extracted from Lemo21(DE3) membranes isolated from
PASM-5052/IPTG cultures as compared to C43(DE3)/LB. This is
signiﬁcantly higher than the 1.5-fold increase from biomass only.
Thus, the whole-cell production level estimates and ﬂow
cytometry data showing the highest production per cell using
Lemo21(DE3)/PASM-5052/IPTG (Fig. 1, Table 2a and d) as well as
the highest fraction of full-length fusion by whole-cell FSEC data
(Supplementary Table 1), are consistent with the larger yields iso-
lated from membranes.
After establishing a satisfactory strain and medium combina-
tion one could next screen different parameters, such as induction
temperatures. However, we have previously shown that by adding
different amounts of L-rhamnose to the medium of Lemo21(DE3)
cells we sufﬁciently cover the ‘‘production space’’ otherwise
achieved by more exhaustive parameter screening [10,30]. None-
theless, it would be useful to deﬁne the best L-rhamnose starting
concentration for screening many targets. As such we next
analysed how production levels of the model targets varied with
different L-rhamnose concentrations, Supplementary Fig. 3. We
found that with 0.25 mM L-rhamnose in the medium, with the
exception of one outlier, the production levels were at least
65% of the (maximal) level that could have otherwise been
reached with the optimal amount of L-rhamnose Fig. 2a, ﬁlled cir-
cles. We also found that the amount of L-rhamnose required in the
medium for optimal protein production varies just as much
between point mutations of the same protein (shown here for
the sodium/proton antiporter NhaA) as it does between unrelated
proteins, Fig. 2a, unﬁlled circles. All our results indicate that
0.25 mM L-rhamnose is the best starting concentration. However,
after the initial selection of the best target and/or mutants thereof,
one should ideally re-screen with different amounts of L-rhamnose
to test for further improvements.
PASM-5052 is formulated speciﬁcally for efﬁcient selenomethi-
onine (Se-Met) incorporation [8], and we ﬁnd only a small reduc-
tion in membrane protein production levels when the culture is
supplemented with selenomethionine, Supplementary Fig. 4. We
have since used Se-Met preparations to facilitate structure deter-
mination of two different bacterial transport proteins expressed
with PASM-5052/IPTG [31] and Lee et al.Ms. submitted; PDB 4ATV].
Taken together, the Lemo21(DE3) strain in combination with
the PASM-5052 medium containing 0.25 mM L-rhamnose and an
IPTG induction step is an effective Membrane protein Single shot
ampliﬁcation recipe (MemStar) that provides high production
levels and is suitable for Se-Met labelling.
3.3. Putting MemStar to the test
To further evaluate the effectiveness of MemStar, we re-
screened a previously constructed bacterial membrane protein
library consisting of 24 targets ranging from low (0.6 mg L1) to
high (27 mg L1) production levels in C43(DE3)/LB. For 17 out of
the 24 targets the normalised mean production levels increased
similarly to the previous results obtained from the ten model
membrane proteins, an increase from 2.8 to 5.2 mg L1 OD6001 ,
(Fig. 2b, Supplementary Table 2a and b). Presumably these num-
bers could be further improved by more exhaustive L-rhamnose
screening. However, for the remaining 7 targets the mean produc-
tion in both C43(DE3)/LB and MemStar cultures is low, 0.67 and
1.1 mg L1 OD6001 , respectively, indicating production levels is unli-
kely to be signiﬁcantly improved with further testing. We estimate
that a membrane production level equivalent to 2.5 mg L1 in
C43(DE3)/LB is required to reliably boost production levels to high
ab
Fig. 2. MemStar and its suitability for high-throughput production screening. (a) Percentage of maximal production by modulation of the T7 RNA polymerase activity across
an L-rhamnose titration series for the 10 target proteins (ﬁlled circles) and NhaA mutant library (unﬁlled circles). The dotted line on the y axis represents P65% maximal
production present in 20 out of 21 cases at 0.25 mM concentration of L-rhamnose. (b) Medium-scale analysis of the application of MemStar (with only 0.25 mM rhamnose)
using an established 24-membrane protein GFP-fusion library. All membrane proteins that are produced to at least 2.5 mg L1 (lowest dotted line) can be increased to above
12.5 mg L1 using MemStar (highest dotted line).
C. Lee et al. / FEBS Letters 588 (2014) 3761–3769 3767levels, deﬁned here as 12.5 mg L1 in MemStar (Supplementary
Table 2a and b). We previously estimated the overproduction
potential for 397 GFP-fusions in a large-scale topology/overpro-
duction analysis of the E. coli inner membrane proteome [29], of
this number, 337 are produced to at least 2.5 mg L1.
There are many reasons why membrane proteins can express
poorly and it seems that MemStar cannot compensate when pro-
duction levels are very low. One reason, for instance, could be that
the speciﬁc function of the target produced has an adverse effect
on cell viability [32]. To test this idea we screened bacterial homo-
logues of two previously tested membrane proteins, EmrD and
GlpG, Supplementary Fig. 5. We likewise found that we could not
signiﬁcantly improve production of the targets produced below
2.5 mg L1 in the C43(DE3)/LB culture condition with MemStar,
arguing against a toxic effect caused by the speciﬁc function of
the target produced, Supplementary Fig. 5. Another reason for poor
production is that some membrane proteins are poorly translated
or have difﬁculties to fold correctly into the membrane, that is,when produced under unnatural cell growth conditions [33]. To
test one of these possibilities, translation inefﬁciency was investi-
gated by comparing one of the poorest producing proteins from the
large-scale GFP-fusion library of the E. coli inner membrane prote-
ome, namely AraH [29] Fig 2b, to a recently constructed codon
optimised version of this protein [34]. With the codon optimised
version of araH its production in C43(DE3)/LB increased from 0.6
to 2.5 mg L1, Supplementary Fig. 5. Using MemStar the codon-
optimised version of araHwas increased to 17 mg L1, signiﬁcantly
more than just the 3-fold increase in biomass obtained from
using the richer PASM-5052 medium.
Thermophilic membrane proteins are thought to be more
stable, but have been noted to be more difﬁcult to produce to high
levels in E. coli [35]. The sodium/proton antiporter NapA from Ther-
mus thermophilus is very stable in detergent solution [3], but pro-
duction levels are low 2.5 mg L1 when cultured in C43(DE3)/
LB. By using MemStar we were able to improve the production
levels to 26 mg L1, Fig. 2b. The increased production yields
Table 4
Price comparisons between the amount of DDM detergent required per mg of puriﬁed
NhaA protein from either C43(DE3)/LB or MemStar cultures.
Buffers required/puriﬁcation Grams of DDM
used (%)
Solubilisation buffer (360 mL total) 3.6 g (1%)
Wash buffer (1 L) 1 g (0.1%)
Dialysis buffer (3 L) 0.9 g (0.03%)
Reverse-IMAC and gel ﬁltration buffer (250 mL) 0.075 g (0.03%)
Total DDM 5.575 g
Cost of DDM/puriﬁcation £162
Cost of DDM/mg of puriﬁed protein (200 lL at 10 mg/mL)
from 5 L cultures using C43(DE3)/LB
£81/mg
Cost of DDM/mg of puriﬁed protein (3000 lL at 10 mg/
mL) from 5 L cultures using MemStar
£5/mg
3768 C. Lee et al. / FEBS Letters 588 (2014) 3761–3769signiﬁcantly facilitated functional investigation as well as puriﬁca-
tion and crystallisation of both Se-Met and native protein [31]. Fur-
thermore, if NapA is cultured in C43(DE3) cells grown in either LB
or TB, only 28% and 10% of the total ﬂuorescence measured from
whole-cells is full-length protein respectively, as compared to
70% in the PASM-5052/IPTG medium (Supplementary Fig. 6). For
NapA, the best crystals were obtained in the small micelle deter-
gent nonyl-D-maltopyranoside (NM) [31]. Because of its low criti-
cal micelle concentration 16 g of NM is required for a single
puriﬁcation with our protocol [36], as compared to only 5.6 g in
DDM. With the establishment of MemStar, however, we were able
to decrease costs and obtain reasonable amounts of protein for
crystal optimisation with a structure obtained to 2.9 Å resolution
[31]. Apart from the metal YiiP transporter, which is the poorest
behaving in our test-set, we could repeat the crystallisation of all
control proteins in MemStar (results not shown), similarly to what
we have shown for a number of these controls produced initially as
GFP-fusions in C43(DE3)/LB [3]. MemStar has further facilitated
structural studies of the dimeric form of the sodium/proton anti-
porter NhaA from E. coli (Lee C et al. Ms in review) and a new
ligand-bound conformational state of the hydantoin transporter
Mhp1 from Microbacterium liquefaciens [37]. Likewise the deter-
gent costs are decreased considerably, for example, for NhaA
structural work, the cost per milligram of DDM puriﬁed protein
is 15-fold lower in MemStar compared to C43(DE3) cells cultured
in LB, Table 4. We stress that these numbers will be completely tar-
get dependent as will the quality of the material isolated. With all
else been equal, however, if one can extract 10-fold more protein
using MemStar then almost certainly the cost per milligram of
puriﬁed protein will be considerably less.
4. Concluding remarks
MemStar offers a one-step approach that in most instances will
signiﬁcantly increase the amount of puriﬁed membrane protein
that can be otherwise isolated from existing E. coli-based mem-
brane protein production platforms with equivalent detergent
usage. In which case, MemStar not only increases the fraction of
highly produced membrane proteins, but because of the higher
yields, it also minimises excessive detergent concentration, which
is a common bottleneck known to hinder crystallisation efforts
[38]. As there is no obvious correlation between membrane protein
stability and production levels (Supplementary Fig. 7), the best
structural targets might be those that can only be produced to
low levels, that is, as was the case for the sodium/proton antiporter
NapA. To our knowledge, MemStar provides the highest production
levels in a simple one-shot production approach that is viewed to
be broadly applicable for facilitating structural and functional stud-
ies of a bacterial membrane protein. Lastly, the ability to produce
larger amounts of protein should facilitate X-ray Free-ElectronLaser experiments, which currently have a higher demand for
puriﬁed protein [39].
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